Amylyx Pharmaceuticals (AMLX) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to -$5.5 million.
- Amylyx Pharmaceuticals' Other Gross PP&E Adjustments fell 737.25% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 737.25%. This contributed to the annual value of -$2.8 million for FY2024, which is 1111.46% up from last year.
- As of Q3 2025, Amylyx Pharmaceuticals' Other Gross PP&E Adjustments stood at -$5.5 million, which was down 737.25% from -$5.8 million recorded in Q2 2025.
- Over the past 5 years, Amylyx Pharmaceuticals' Other Gross PP&E Adjustments peaked at $250000.0 during Q4 2021, and registered a low of -$6.8 million during Q1 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$4.4 million (2023), whereas its average is -$4.2 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 177080.0% in 2022, then surged by 6137.76% in 2025.
- Quarter analysis of 5 years shows Amylyx Pharmaceuticals' Other Gross PP&E Adjustments stood at $250000.0 in 2021, then crashed by 1770.8% to -$4.2 million in 2022, then rose by 23.32% to -$3.2 million in 2023, then increased by 11.11% to -$2.8 million in 2024, then crashed by 92.34% to -$5.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$5.5 million in Q3 2025, compared to -$5.8 million in Q2 2025 and -$1.3 million in Q1 2025.